Chemical Properties | Back Directory | [Boiling point ]
757.5±60.0 °C(Predicted) | [density ]
1.407±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
11.46±0.40(Predicted) | [color ]
White to off-white |
Hazard Information | Back Directory | [Uses]
BMS-986299 (compound 112) is a first-in-class NLRP3 inflammasome agonist with an EC50 of 1.28 μM. (patent WO2018152396A1). | [IC 50]
NLRP3: 1.28 μM (EC50) | [References]
[1] Gary Glick, et al. Substituted imidazo-quinolines as nlrp3 modulators. WO2018152396A1. [2] Gao G, et al., Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro. Front Pharmacol. 2022 Jul 5;13:906548. DOI:10.3389/fphar.2022.906548 |
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
|